Literature DB >> 23639842

Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil.

Felipe F Tuon, Jaime L Rocha, Marina S Formighieri, Samiria Sfair, Mariana B Bertoldi, Jussara Kasuko Palmeiro, Libera Maria Dalla Costa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23639842     DOI： 10.1016/j.jinf.2013.04.017

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  9 in total

Review 1.  Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.

Authors:  Elizabeth A Neuner; Jason C Gallagher
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

Review 2.  The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms.

Authors:  Ann Marie Porreca; Kaede V Sullivan; Jason C Gallagher
Journal:  Curr Infect Dis Rep       Date:  2018-05-05       Impact factor: 3.725

Review 3.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 4.  Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.

Authors:  Haley J Morrill; Jason M Pogue; Keith S Kaye; Kerry L LaPlante
Journal:  Open Forum Infect Dis       Date:  2015-05-05       Impact factor: 3.835

Review 5.  Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.

Authors:  Ilias Karaiskos; Helen Giamarellou
Journal:  Expert Opin Pharmacother       Date:  2014-04-28       Impact factor: 3.889

6.  Evaluation Strategies for Triple-Drug Combinations against Carbapenemase-Producing Klebsiella Pneumoniae in an In Vitro Hollow-Fiber Infection Model.

Authors:  Estefany Garcia; John K Diep; Rajnikant Sharma; Patrick O Hanafin; Cely S Abboud; Keith S Kaye; Jian Li; Tony Velkov; Gauri G Rao
Journal:  Clin Pharmacol Ther       Date:  2021-03-04       Impact factor: 6.875

7.  Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Yi-Chien Lee; Pao-Yu Chen; Jann-Tay Wang; Shan-Chwen Chang
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-17       Impact factor: 4.887

8.  KPC-producing Enterobacter aerogenes infection.

Authors:  Felipe F Tuon; Camila Scharf; Jaime L Rocha; Juliette Cieslinsk; Guilherme Nardi Becker; Lavinia N Arend
Journal:  Braz J Infect Dis       Date:  2015-02-23       Impact factor: 3.257

9.  Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae.

Authors:  Felipe F Tuon; Maria Esther Graf; Alexandre Merlini; Jaime L Rocha; Suellen Stallbaum; Lavinia N Arend; Roberto Pecoit-Filho
Journal:  Braz J Infect Dis       Date:  2016-11-04       Impact factor: 3.257
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.